ARCHIVES

The Tivozanib Timeline

This article is from The Cancer Letter archive.

Vol. 39 No. 19 | May 10, 2013

Download PDF Visit The Full Archive

Related Articles

FDA’s Young Still Not Satisfied With Distribution Plan

September 9, 1977

ODAC Reviews Post-Marketing Studies for Eight Indications

March 21, 2003

More Cost-Effective To Use Cetuximab In Patients With Wild-Type KRAS Gene

August 28, 2009

CMS Proposal To Limit ESA Use Is Too Much, Too Fast, Critics Say.

May 18, 2007

Holden, Mayo, Hopkins Win Lymphoma SPOREs; Hutchinson Wins Prostate SPORE

October 4, 2002

NCI Seeks CRADA Partners To Develop Targets Drugs

October 24, 1997